- Journal of Experimental and Clinical Medicine
- Volume:9 Issue:3-4
- Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups
Prevalence Of Hepatitis C Virus Antibadies İn Different Patient Groups
Authors : B DURUPINAR, A SANİÇ, M GÜNAYDIN, M PİİRİNÇCİLER
Pages : 0-0
Doi:10.5835/jecm.v9i3-4.434
View : 38 | Download : 9
Publication Date : 2009-12-22
Article Type : Other Papers
Abstract :The hepatitis C Virus insert ignore into journalissuearticles values(HCV); is now known to be the chief cause of transfusion-associated non-A non-B hepatitis insert ignore into journalissuearticles values(NANBH);. The prevalence of HCV infection was as-sessed by means of Abbott enzyme-linked immunosorbent assay for serum anti-HCV antibodies. 2222 serum samples were selected from different patient groups, accor¬ding to their risk of blood-borne viral infections. Anti-HCV antibodies were detected in 25 of 83 insert ignore into journalissuearticles values(30.12%); risk group insert ignore into journalissuearticles values(Haemodialysis patients and polytransfused patients with haemophilia, thalassemia, patients of cardiac surgery);. Among healtyh subjects, wit¬hout risk factors for hepatitis, the overall prevalance of Anti-HCV was insert ignore into journalissuearticles values(0.14%);. Hepatit C virusu insert ignore into journalissuearticles values(HCV);, transfüzyon ile ilişkili non-A, non-B hepatiti insert ignore into journalissuearticles values(NANBH);`nin başlıca nedenidir. HCV infeksiyon prevalansı Abbott`un anti-HCV antikorları için enzy-me-linked immunosorbent assay insert ignore into journalissuearticles values(ELISA); test kiti kullanılarak saptanmıştır. 2222 serum örneği, kan yoluyla viral infeksiyon bulaşma riski olan değişik hasta gruplarından toplanmıştır. Anti-HCV antikorları 83 risk grubunun insert ignore into journalissuearticles values(hemodiyaliz hastası, he¬mofili, thalassemi gibi politransfüze hastalar ve kalp cerrahisi hastaları); 25 insert ignore into journalissuearticles values(%30.12);`inde saptanmıştır. Hepatit risk faktörü bulunmayan sağlıklı bireylerde anti-HCV prevalansı ise %0.14 olarak saptanmıştır.Keywords :
ORIGINAL ARTICLE URL